<DOC>
	<DOCNO>NCT01619748</DOCNO>
	<brief_summary>Peripheral vascular function impaired people obstructive sleep apnoea untreated compare age- , weight- sex-matched healthy control .</brief_summary>
	<brief_title>Peripheral Vascular Function Obstructive Sleep Apnoea</brief_title>
	<detailed_description>Obstructive sleep apnoea ( OSA ) chronic respiratory disorder associate endothelial dysfunction , increase sympathetic activation increase cardiovascular risk . The standard treatment paradigm continuous positive airway pressure ( CPAP ) , however , patient adherence CPAP variable . It unclear extent poor adherence CPAP therapy augments vascular endothelial function reduces cardiovascular risk compare excellent adherence . The main aim research investigate vascular endothelial function OSA patient poorly-adherent CPAP therapy . Nitric oxide ( NO ) -mediated , endothelium-dependent macrovascular microvascular function ( brachial artery flow-mediated dilatation forearm cutaneous thermal hyperaemia , respectively ) generalise microvascular function ( post-occlusion reactive hyperaemia ) assess three obese OSA patient population ( high-adherence ( n=20 ) ; low adherence ( n=20 ) ; , untreated ( n=20 ) ) age-/BMI-matched OSA-free control . We also assess body composition , cardiovascular risk , lipid status functional capacity . This research evaluate treatment efficacy patient poorly-adherent CPAP treatment could identify whether alternative approach care explore .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Obstructive sleep apnoea diagnose use overnight polysomnography Age 1890 year Unable perform test involve study Unable provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>